Selected Grants
Genomic determinants of antibiotic treatment failure in S. aureus bacteremia
ResearchMentor · Awarded by National Institutes of Health · 2024 - 2029Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education Program
Inst. Training Prgm or CMEMentor · Awarded by National Institute of General Medical Sciences · 2022 - 2027Staphylococcus aureus Cardiac Device Infections - From the Vascular Viewpoint (K23)
ResearchMentor · Awarded by National Heart, Lung, and Blood Institute · 2022 - 2027Characterization of a Novel E. coli Type III Secretion System Associated with Increased Patient Mortality
ResearchMentor · Awarded by National Institutes of Health · 2022 - 2027Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)
Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2022 - 2026Antibacterial Resistance Leadership Group (ARLG)
ResearchPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2013 - 2026HLA Fine Mapping to Elucidate S. aureus Susceptibility - R01 RPPR
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2026UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2016 - 2026Defining an evidence-based clinical development framework for the evaluation of decolonization agents used for the prevention of serious bacterial infections
ResearchPrincipal Investigator · Awarded by Boston University · 2024 - 2026Evaluate pathogen characteristics and host specific characteristics in hemodialysis patients with Staphylococcus aureus bloodstream infections
ResearchPrincipal Investigator · Awarded by MedImmune Limited · 2023 - 2025Klebsiella Isolate Study
ResearchPrincipal Investigator · Awarded by MedImmune Limited · 2025 - 2025Proof of Principle Study
ResearchPrincipal Investigator · Awarded by Research of Technologies and Biophotonics LTD · 2024 - 2025A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Single Dose of Exebacase in Adult Patients Receiving Standard of Care Antibiotics for the Treatment of Staphylococcus aureus Bloodstream Infections (Bacteremia),
Clinical TrialPrincipal Investigator · Awarded by ContraFect Corporation · 2020 - 2024Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTG)
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024Duke CTSA (TL1) Year 5
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024Innate immune induction of antibiotic tolerance and resistance in Staphylococcus aureus - R56 Bridge Funding (for R01 submission)
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2022 - 2024Parsons UNC Interinstitutional Agreement
FellowshipPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2021 - 2024Characterizing the quality of life impact of complicated urinary tract infections caused by gram-negative bacteria
ResearchCo-Principal Investigator · Awarded by Merck Sharp & Dohme · 2021 - 2024Postdoctoral Training in Genomic Medicine Research
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2017 - 2023A Photochemically 3D Printed High-Resolution Biodegradable Suture Retention Clip
ResearchPrincipal Investigator · Awarded by Deep Blue Medical Advances Inc · 2022 - 2023CEC Activities for BPR-CS-009 Ceftobiprole medocaril - WO2
Clinical TrialPrincipal Investigator · Awarded by Basilea Pharmaceutica · 2018 - 2022CEC Activities for BPR-CS-009 Ceftobiprole medocaril
Clinical TrialPrincipal Investigator · Awarded by Basilea Pharmaceutica · 2017 - 2022Novel Diagnostics to Improve Antimicrobial Stewardship for Acute Respiratory Tract Infections in Resource-Limited Settings
ResearchMentor · Awarded by National Institutes of Health · 2017 - 2022Computational Structure-Based Protein Design Non-competing Renewal (Yr. 12)
ResearchCollaborating Investigator · Awarded by National Institutes of Health · 2008 - 2022Mentoring Patient Oriented Research in Antibiotic-Resistant Bacteria
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2022Vaccine Trial_LOI
ResearchPrincipal Investigator · Awarded by Universitair Medisch Centrum Utrecht · 2019 - 2021Systems Immunobiology of Antibiotic-Persistent MRSA Infections
ResearchPrincipal Investigator · Awarded by The Lundquist Institute · 2016 - 2021UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2020 - 2021Diagnosis of Bacteremia/Septicemia by the Karius sequencing-based Infectious disease diagnostic assay
Clinical TrialPrincipal Investigator · Awarded by Karius, Inc. · 2016 - 2021Study of Prognostic Biomarkers of Severe Systemic Bacterial Infection
ResearchPrincipal Investigator · Awarded by Genetech · 2016 - 2020A phase 1b, randomized, double-blind, placebo-controlled, multiple-ascending dose study to investigate the safety, tolerability and pharmacokinetics of DSTA4637A in patients with Staphylococcus Aureus Bacteremia receiving standard-of-care antibiotics
Clinical TrialPrincipal Investigator · Awarded by Genentech, Inc. · 2017 - 2020An Evaluation of Clinical Characteristics, Treatment Patterns and Outcomes in the Staphylococcus aureus Bacteremia Group Prospective Cohort Study (SABG-PCS)
ResearchPrincipal Investigator · Awarded by Genentech, Inc. · 2018 - 2020Study Network of Acinetobacter as a XDR pathogen (SNAP)
Clinical TrialPrincipal Investigator · Awarded by University of Pittsburgh · 2018 - 2020CF-301-102 Study
Clinical TrialPrincipal Investigator · Awarded by ContraFect Corporation · 2016 - 2020Forces at the heart of Staphylococcus biofilms on cardiac implants
ResearchPrincipal Investigator · Awarded by Ohio State University · 2014 - 2020Host Susceptibility to S. aureus
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2020CAMERA: Combination antibiotic treatment for Methicillin Resistant Staphylococcus Aureus Bacteraemia-a Randomized Controlled Trial
ResearchPrincipal Investigator · Awarded by Menzies School of Health Research · 2015 - 2019ARLG Administrative Supplement
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2019One Health Innovation Fellowships for Zoonotic Disease Research in Mongolia
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2013 - 2019Optimizing treatment for E. faecalis infective endocarditis: ampicillin plus ceftriaxone versus ampicillin plus gentamicin
ResearchCo Investigator · Awarded by National Institutes of Health · 2016 - 2019Elucidating the role of Ceftaroline Fosamil in the treatment of meningitis caused by Methicillin-Resistant Staphylococcs aureus using Rabbit model
ResearchMentor · Awarded by Allergan, Inc. · 2016 - 2018Bacteremia Modification 14
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2017Mod 11 for Option 3 - Staphylococcal Bacteremia Study
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2017Modification No 13 Staphylococcal Bacteremia Study
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2017Institutional Training Grant in Pediatric Infectious Disease
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2011 - 2016Modification No. 8 - Staphylococcal Bacteremia Study
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2016Cross-reactive Antibodies to CF-301 Associated with Staphylococcus aureus Bacteremia in a Tertiary Medical Center in the Southeastern United States
ResearchPrincipal Investigator · Awarded by ContraFect Corporation · 2016 - 2016Comparison of Subjects with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia treated with Ceftaroline Fosamil to Historical Controls not treated with Ceftaroline Fosamil
Clinical TrialPrincipal Investigator · Awarded by Forest Research Institute · 2013 - 2016Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Community Hospital
ResearchCo-Mentor · Awarded by National Institutes of Health · 2011 - 2016A Four-arm Prospective, Multicenter Study to Assess the Clinical Efficacy, Effectiveness, and Feasibility of Enhanced Room Disinfection with Chlorine and UV light Using Clinical and Microbiologic Outcomes
Clinical TrialInvestigator · Awarded by Centers for Disease Control and Prevention · 2011 - 2016Evaluation of the Efficacy of Personal Protective Equipment and Antiseptic Impregnated Clothing in Reducing Exposure of Health Care Personnel to Acquisition and Transmission of Viral and Bacterial Pat
Clinical TrialInvestigator · Awarded by Centers for Disease Control and Prevention · 2015 - 2016Modification No. 5 - Staphylococcal Bacteremia Study
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2015Optimizing duration of antibiotics after valve surgery for infective endocarditis
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2012 - 2014A Phase III Multi-Center, Randomized, Open-label, Comparative Study to Assess the Efficacy of a Treatment Algorithm to Reduce the Use of Vancomycin in Patients with Intravenous Catheter-Associated Bloodstream Infections (BSI) due to Staphylococci
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2012Immune System Biological Networks:Case Study Improved Data Integration & Analysis
ResearchCo Investigator · Awarded by National Institutes of Health · 2008 - 2010Virulence determinants in S. aureus bacteremia
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2004 - 2008Towards an Understanding of the Pathophysiology and Clinical Outcomes of Patients w/Endocarditis
ResearchCollaborator · Awarded by National Institutes of Health · 2002 - 2006Towards an Understanding of the Pathogenesis of Staphylococcus Aureus Bacteremia
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1999 - 2005External Relationships
- Akagera
- Armata
- AstraZeneca
- Basilea
- Contrafect
- DebioPharma
- GSK
- Indiana University
- MicuRx
- Northwestern University
- Remington Winter Course in Infectious Diseases
- Valanbio Therapeutics
- Wolters Kluwer Health (publishing)
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.